Skip to main content
Log in

Existing drugs and their application in drug discovery targeting cancer stem cells

  • Review
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Despite standard cancer therapies such as chemotherapy and targeted therapy have shown some efficacies, the cancer in many cases eventually relapses and metastasizes upon stopping the treatment. There is a small subpopulation of cancer cells within tumor, with specific characters similar to those found in stem cells. This group of cancer cells is known as tumor-initiating or cancer stem cells (CSCs), which have an ability to self-renew and give rise to cancer cell progeny. CSCs are related with drug resistance, metastasis and relapse of cancer, hence emerging as a crucial drug target for eliminating cancer. Rapid advancement of CSC biology has enabled researchers to isolate and culture CSCs in vitro, making the cells amenable to high-throughput drug screening. Recently, drug repositioning, which utilizes existing drugs to develop potential new indications, has been gaining popularity as an alternative approach for the drug discovery. As existing drugs have favorable bioavailability and safety profiles, drug repositioning is now actively exploited for prompt development of therapeutics for many serious diseases, such as cancer. In this review, we will introduce latest examples of attempted drug repositioning targeting CSCs and discuss potential use of the repositioned drugs for cancer therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Abdullah, L.N., and E.K. Chow. 2013. Mechanisms of chemoresistance in cancer stem cells. Clinical and Translational Medicine 2: 3.

    Article  PubMed Central  PubMed  Google Scholar 

  • Abel, E.V., E.J. Kim, J. Wu, M. Hynes, F. Bednar, E. Proctor, L. Wang, M.L. Dziubinski, and D.M. Simeone. 2014. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. PLoS One 9: e91983.

    Article  PubMed Central  PubMed  Google Scholar 

  • Abubaker, K., R.B. Luwor, H. Zhu, O. McNally, M.A. Quinn, C.J. Burns, E.W. Thompson, J.K. Findlay, and N. Ahmed. 2014. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. BMC Cancer 14: 317.

    Article  PubMed Central  PubMed  Google Scholar 

  • Ahn, H.J., G. Kim, and K.S. Park. 2013. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway. Biochemical and Biophysical Research Communications 437: 557–564.

    Article  CAS  PubMed  Google Scholar 

  • Al-Hadiya, B. 2004. Niclosamide: Comprehensive profile. Profiles of Drug Substances, Excipients and Related Methodology 32: 67–96.

    Article  Google Scholar 

  • Al-Hajj, M., M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke. 2003. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences USA 100: 3983–3988.

    Article  CAS  Google Scholar 

  • Ashburn, T.T., and K.B. Thor. 2004. Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery 3: 673–683.

    Article  CAS  PubMed  Google Scholar 

  • Augustijns, P., P. Geusens, and N. Verbeke. 1992. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. European Journal of Clinical Pharmacology 42: 429–433.

    CAS  PubMed  Google Scholar 

  • Axelson, M., K. Liu, X. Jiang, K. He, J. Wang, H. Zhao, D. Kufrin, T. Palmby, Z. Dong, A.M. Russell, S. Miksinski, P. Keegan, and R. Pazdur. 2013. U.S. Food and Drug Administration approval: Vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma. Clinical Cancer Research 19: 2289–2293.

    Article  CAS  PubMed  Google Scholar 

  • Bailey, C.J., and C. Day. 2004. Metformin: Its botanical background. Practical Diabetes International 21: 115–117.

    Article  Google Scholar 

  • Bailey, C.J., and R.C. Turner. 1996. Metformin. New England Journal of Medicine 334: 574–579.

    Article  CAS  PubMed  Google Scholar 

  • Balic, A., M.D. Sorensen, S.M. Trabulo, B. Sainz Jr, M. Cioffi, C.R. Vieira, I. Miranda-Lorenzo, M. Hidalgo, J. Kleeff, M. Erkan, and C. Heeschen. 2014. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. Molecular Cancer Therapeutics 13: 1758–1771.

    Article  CAS  PubMed  Google Scholar 

  • Bao, B., Z. Wang, S. Ali, A. Ahmad, A.S. Azmi, S.H. Sarkar, S. Banerjee, D. Kong, Y. Li, S. Thakur, and F.H. Sarkar. 2012. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prevention Research 5: 355–364.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cai, W.Y., T.Z. Wei, Q.C. Luo, Q.W. Wu, Q.F. Liu, M. Yang, G.D. Ye, J.F. Wu, Y.Y. Chen, and G.B. Sun. 2013. The Wnt–β-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion. Journal of Cell Science 126: 2877–2889.

    Article  CAS  PubMed  Google Scholar 

  • Chen, K., Y.H. Huang, and J.L. Chen. 2013. Understanding and targeting cancer stem cells: Therapeutic implications and challenges. Acta Pharmacologica Sinica 34: 732–740.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Chen, M., J. Wang, J. Lu, M.C. Bond, X.R. Ren, H.K. Lyerly, L.S. Barak, and W. Chen. 2009. The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. Biochemistry 48: 10267–10274.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Choi, D.S., E. Blanco, Y.S. Kim, A.A. Rodriguez, H. Zhao, T.H. Huang, C.L. Chen, G.X. Jin, M.D. Landis, L.A. Burey, W. Qian, S.M. Granados, B. Dave, H.H. Wong, M. Ferrari, S.T. Wong, and J.C. Chang. 2014. Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1. Stem Cells 32: 2309–2323.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Chong, C.R., X. Chen, L. Shi, J.O. Liu, and D.J. Sullivan Jr. 2006. A clinical drug library screen identifies astemizole as an antimalarial agent. Nature Chemical Biology 2: 415–416.

    Article  CAS  PubMed  Google Scholar 

  • Collins, A.T., P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland. 2005. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 65: 10946–10951.

    Article  CAS  PubMed  Google Scholar 

  • Curley, M.D., V.A. Therrien, C.L. Cummings, P.A. Sergent, C.R. Koulouris, A.M. Friel, D.J. Roberts, M.V. Seiden, D.T. Scadden, B.R. Rueda, and R. Foster. 2009. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells. 27: 2875–2883.

  • Czyz, D.M., L.P. Potluri, N. Jain-Gupta, S.P. Riley, J.J. Martinez, T.L. Steck, S. Crosson, H.A. Shuman, and J.E. Gabay. 2014. Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens. mBio 5: e01534; 14.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Dalerba P, S.J. Dylla, I.K. Park, R. Liu, X.H. Wang, R.W. Cho, T. Hoey, A. Gurney, E.H. Huang, D.M. Simeone, A.A Shelton, G. Parmiani, C. Castelli, and M.F. Clarke. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences USA 104: 10158–10163.

  • Dean, M. 2009. ABC transporters, drug resistance, and cancer stem cells. Journal of Mammary Gland Biology Neoplasia 14: 3–9.

    Article  PubMed  Google Scholar 

  • DeCastro, A.J., P. Cherukuri, A. Balboni, J. DiRenzo. 2015. ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis. Molecular Cancer Therapeutics 14: 225–235.

  • Diamandis, P., J. Wildenhain, I.D. Clarke, A.G. Sacher, J. Graham, D.S. Bellows, E.K. Ling, R.J. Ward, L.G. Jamieson, M. Tyers, and P.B. Dirks. 2007. Chemical genetics reveals a complex functional ground state of neural stem cells. Nature Chemical Biology 3: 268–273.

    Article  CAS  PubMed  Google Scholar 

  • Doudican, N., A. Rodriguez, I. Osman, and S.J. Orlow. 2008. Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Molecular Cancer Research 6: 1308–1315.

    Article  CAS  PubMed  Google Scholar 

  • Eramo, A., F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, A. Di Virgilio, C. Conticello, L. Ruco, C. Peschle, and R.De Maria. 2008. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death & Differentiation 15: 504–514.

  • Fang, D., T.K. Nguyen, K. Leishear, R. Finko, A.N. Kulp, S. Hotz, P.A. Van Belle, X.W. Xu, D.E. Elder, M. Herlyn. 2005. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Research 65: 9328–9337.

  • Finsterer, J., and M. Frank. 2013. Repurposed drugs in metabolic disorders. Current Topics in Medicinal Chemistry 13: 2386–2394.

    Article  CAS  PubMed  Google Scholar 

  • Frayha, G.J., J.D. Smyth, J.G. Gobert, and J. Savel. 1997. The mechanisms of action of antiprotozoal and anthelmintic drugs in man. General Pharmacology 28: 273–299.

    Article  CAS  PubMed  Google Scholar 

  • Gibbs, C.P., V.G. Kukekov, J.D. Reith, O. Tchigrinova, O.N. Suslov, E.W. Scott, S.C. Ghivizzani, T.N Ignatova, and D.A. Steindler. 2005. Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia. 7: 967–976.

  • Gupta, P.B., T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R.A. Weinberg, and E.S. Lander. 2009. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645–659.

    Article  CAS  PubMed  Google Scholar 

  • Hempelmann, E. 2007. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Parasitology Research 100: 671–676.

    Article  PubMed  Google Scholar 

  • Hermann, P.C., S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, M. Guba, C.J. Bruns, and C. Heeschen. 2007. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 1: 313–323.

  • Hothi, P., T.J. Martins, L.P. Chen, L. Deleyrolle, J.G. Yoon, B. Reynolds, and G. Foltz. 2012. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells. Oncotarget 3: 1124–1136.

    PubMed Central  PubMed  Google Scholar 

  • Huang, E.H., M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J.Z. Fields, M.S. Wicha, and B.M. Boman. 2009. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Research 69: 3382–3389.

  • Huang, R., N. Southall, Y. Wang, A. Yasgar, P. Shinn, A. Jadhav, D.T. Nguyen, and C.P. Austin. 2011. The NCGC pharmaceutical collection: A comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Science Translational Medicine 3: 80ps16.

    Article  PubMed Central  PubMed  Google Scholar 

  • Jiang, R., Y. Li, A. Zhang, B. Wang, Y. Xu, W. Xu, Y. Zhao, F. Luo, and Q. Liu. 2014. The acquisition of cancer stem cell-like properties and neoplastic transformation of human keratinocytes induced by arsenite involves epigenetic silencing of let-7c via Ras/NF-κB. Toxicology Letters 227: 91–98.

    Article  CAS  PubMed  Google Scholar 

  • Ketley, A., C.Z. Chen, X. Li, S. Arya, T.E. Robinson, J. Granados-Riveron, I. Udosen, G.E. Morris, I. Holt, D. Furling, S. Chaouch, B. Haworth, N. Southall, P. Shinn, W. Zheng, C.P. Austin, C.J. Hayes, and J.D. Brook. 2014. High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. Human Molecular Genetics 23: 1551–1562.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Khanim, F.L., B.A. Merrick, H.V. Giles, M. Jankute, J.B. Jackson, L.J. Giles, J. Birtwistle, C.M. Bunce, and M.T. Drayson. 2011. Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production. Blood Cancer Journal 1: e39.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kim, C.F., E.L. Jackson, A.E. Woolfenden, S. Lawrence, I. Babar, S. Vogel, D. Crowley, R.T. Bronson, and T. Jacks. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823–835.

  • Kimlin, L.C., G. Casagrande, and V.M. Virador. 2013. In vitro three-dimensional (3D) models in cancer research: An update. Molecular Carcinogenesis 52: 167–182.

    Article  PubMed  Google Scholar 

  • Kimura, T., Y. Takabatake, A. Takahashi, and Y. Isaka. 2013. Chloroquine in cancer therapy: A double-edged sword of autophagy. Cancer Research 73: 3–7.

    Article  CAS  PubMed  Google Scholar 

  • Krafts, K., E. Hempelmann, and A. Skorska-Stania. 2012. From methylene blue to chloroquine: A brief review of the development of an antimalarial therapy. Parasitology Research 111: 1–6.

    Article  PubMed  Google Scholar 

  • Lapidot, T., C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M.A. Caligiuri, and J.E. Dick. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645–648.

    Article  CAS  PubMed  Google Scholar 

  • Li, C., D.G. Heidt, P. Dalerba, C.F. Burant, L. Zhang, V. Adsay, M. Wicha, M.F. Clarke, and D.M. Simeone. 2007. Identification of pancreatic cancer stem cells. Cancer Research 67: 1030–1037.

    Article  CAS  PubMed  Google Scholar 

  • Li, R., Z.L. Hu, S.Y. Sun, Z.G. Chen, T.K. Owonikoko, G.L. Sica, S.S. Ramalingam, W.J. Curran, F.R. Khuri, and X.M. Deng. 2013. Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer. Molecular Cancer Therapeutics 12: 2200–2212.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Li, Y., P.K. Li, M.J. Roberts, R.C. Arend, R.S. Samant, and D.J. Buchsbaum. 2014. Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Letters 349: 8–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Liu, P.P., J. Liao, Z.J. Tang, W.J. Wu, J. Yang, Z.L. Zeng, Y. Hu, P. Wang, H.Q. Ju, R.H. Xu, and P. Huang. 2014. Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway. Cell Death and Differentiation 21: 124–135.

    Article  PubMed Central  PubMed  Google Scholar 

  • Liu, S., G. Dontu, I.D. Mantle, S. Patel, N.S. Ahn, K.W. Jackson, P. Suri, and M.S. Wicha. 2006. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Research 66: 6063–6071.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lonardo, E., M. Cioffi, P. Sancho, Y. Sanchez-Ripoll, S.M. Trabulo, J. Dorado, A. Balic, M. Hidalgo, and C. Heeschen. 2013. Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. PLoS One 8: e76518.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lu, W., C. Lin, M.J. Roberts, W.R. Waud, G.A. Piazza, and Y. Li. 2011. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/beta-catenin pathway. PLoS One 6: e29290.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lucis, O.J. 1983. The status of metformin in Canada. Canadian Medical Association Journal 128: 24–26.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Ma, I., and A.L. Allan. 2011. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Reviews and Reports 7: 292–306.

    Article  CAS  PubMed  Google Scholar 

  • Madiraju, A.K., D.M. Erion, Y. Rahimi, X.M. Zhang, D.T. Braddock, R.A. Albright, B.J. Prigaro, J.L. Wood, S. Bhanot, M.J. MacDonald, M.J. Jurczak, J.P. Camporez, H.Y. Lee, G.W. Cline, V.T. Samuel, R.G. Kibbey, and G.I. Shulman. 2014. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510: 542–546.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mani, S.A., W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704–715.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mei, F., S.P. Fancy, Y.A. Shen, J. Niu, C. Zhao, B. Presley, E. Miao, S. Lee, S.R. Mayoral, S.A. Redmond, A. Etxeberria, L. Xiao, R.J. Franklin, A. Green, S.L. Hauser, and J.R. Chan. 2014. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nature Medicine 20: 954–960.

    Article  CAS  PubMed  Google Scholar 

  • Meinao, I., E. Sato, L. Andrade, M. Ferraz, and E. Atra. 1996. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. Lupus 5: 237–241.

    Article  CAS  PubMed  Google Scholar 

  • Michor, F., T.P. Hughes, Y. Iwasa, S. Branford, N.P. Shah, C.L. Sawyers, and M.A. Nowak. 2005. Dynamics of chronic myeloid leukaemia. Nature 435: 1267–1270.

    Article  CAS  PubMed  Google Scholar 

  • Mizushima, T. 2011. Drug discovery and development focusing on existing medicines: Drug re-profiling strategy. Journal of Biochemistry 149: 499–505.

    Article  CAS  PubMed  Google Scholar 

  • O’Brien, C.A., A. Pollett, S. Gallinger, and J.E. Dick. 2006. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106–110.

    Article  PubMed  Google Scholar 

  • Oktem, G., O. Sercan, U. Guven, R. Uslu, A. Uysal, G. Goksel, S. Ayla, and A. Bilir. 2014. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids. Oncology Reports 32: 641–649.

    CAS  PubMed  Google Scholar 

  • Osada, T., M. Chen, X.Y. Yang, I. Spasojevic, J.B. Vandeusen, D. Hsu, B.M. Clary, T.M. Clay, W. Chen, M.A. Morse, and H.K. Lyerly. 2011. Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Research 71: 4172–4182.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Owen, M.R., E. Doran, and A.P. Halestrap. 2000. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal 348: 607–614.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Pearson, R.D., and E.L. Hewlett. 1985. Niclosamide therapy for tapeworm infections. Annals of Internal Medicine 102: 550–551.

    Article  CAS  PubMed  Google Scholar 

  • Prince, M., R. Sivanandan, A. Kaczorowski, G. Wolf, M. Kaplan, P. Dalerba, I. Weissman, M. Clarke, L. Ailles. 2007. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences USA 104: 973–978.

  • Ren, X.M., L. Duan, Q.A. He, Z. Zhang, Y. Zhou, D.H. Wu, J.X. Pan, D.Q. Pei, and K. Ding. 2010. Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Medicinal Chemistry Letters 1: 454–459.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ricci-Vitiani, L., D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, and R. De Maria. 2006. Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111–115.

    Article  PubMed  Google Scholar 

  • Robinson, T.J., M. Pai, J.C. Liu, F. Vizeacoumar, T. Sun, S.E. Egan, A. Datti, J. Huang, and E. Zacksenhaus. 2013. High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells Interaction with IQ motif-containing factors. Cell Cycle 12: 3013–3024.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rosen, J.M., and C.T. Jordan. 2009. The increasing complexity of the cancer stem cell paradigm. Science 324: 1670–1673.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sabet, M.N., A. Rakhshan, E. Erfani, and Z. Madjd. 2010. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors. Asian Pacific Journal of Cancer Prevention 15: 8161–8169.

  • Schatton, T., G.F. Murphy, N.Y. Frank, K. Yamaura, A.M. Waaga-Gasser, M. Gasser, Q. Zhan, S. Jordan, L.M. Duncan, C. Weishaupt, R.C. Fuhlbrigge, T.S. Kupper, M.H. Sayegh, and M.H. Frankz. 2008. Identification of cells initiating human melanomas. Nature 451: 345–349.

  • Shaw, R.J., K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, R.A. Depinho, M. Montminy, and L.C. Cantley. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642–1646.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shim, J.S., Y. Matsui, S. Bhat, B.A. Nacev, J. Xu, H.E. Bhang, S. Dhara, K.C. Han, C.R. Chong, M.G. Pomper, A. So, and J.O. Liu. 2010. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. Journal of the National Cancer Institute 102: 1855–1873.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shim, J.S., R. Rao, K. Beebe, L. Neckers, I. Han, R. Nahta, and J.O. Liu. 2012. Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. Journal of the National Cancer Institute 104: 1576–1590.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Siegel, R., J.M. Ma, Z.H. Zou, and A. Jemal. 2014. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians 64: 9–29.

    Google Scholar 

  • Singh, S.K., C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano, and P.B. Dirks. 2004. Identification of human brain tumour initiating cells. Nature 432: 396–401.

    Article  CAS  PubMed  Google Scholar 

  • Solomon, V.R., and H. Lee. 2009. Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies. European Journal of Pharmacology 625: 220–233.

    Article  CAS  PubMed  Google Scholar 

  • Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58–62.

    Article  CAS  PubMed  Google Scholar 

  • Story, P., and A. Doube. 2004. A case of human poisoning by salinomycin, an agricultural antibiotic. New Zealand Medical Journal 117: U799.

    PubMed  Google Scholar 

  • Strittmatter, S.M. 2014. Overcoming drug development bottlenecks with repurposing: Old drugs learn new tricks. Nature Medicine 20: 590–591.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Tirino, V., V. Desiderio, F. Paino, G. Papaccio, and M. De Rosa. 2012. Methods for cancer stem cell detection and isolation. Methods in Molecular Biology 879: 513–529.

    Article  CAS  PubMed  Google Scholar 

  • Tseng, C.N., Y.R. Hong, H.W. Chang, T.J. Yu, T.W. Hung, M.F. Hou, S.S. Yuan, C.L. Cho, C.T. Liu, C.C. Chiu, and C.J. Huang. 2014. Brefeldin A reduces anchorage-independent survival, cancer stem cell potential and migration of MDA-MB-231 human breast cancer cells. Molecules 19: 17464–17477.

  • Vinogradov, S., and X. Wei. 2012. Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine (London) 7: 597–615.

    Article  PubMed Central  CAS  Google Scholar 

  • Visvader, J.E., and G.J. Lindeman. 2008. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nature Reviews Cancer 8: 755–768.

    Article  CAS  PubMed  Google Scholar 

  • Wang, A.M., H.H. Ku, Y.C. Liang, Y.C. Chen, Y.M. Hwu, and T.S. Yeh. 2009. The autonomous Notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in k562 cells. Journal of Cellular Biochemistry 106: 682–692.

    Article  CAS  PubMed  Google Scholar 

  • Wang, Y.C., T.K. Chao, C.C. Chang, Y.T. Yo, M.H. Yu, and H.C. Lai. 2013. Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells. PLoS One 8: e74538.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Weiswald, L.B., D. Bellet, and V. Dangles-Marie. 2015. Spherical cancer models in tumor biology. Neoplasia 17: 1–15.

    Article  PubMed Central  PubMed  Google Scholar 

  • Wieland, A., D. Trageser, S. Gogolok, R. Reinartz, H. Hofer, M. Keller, A. Leinhaas, R. Schelle, S. Normann, L. Klaas, A. Waha, P. Koch, R. Fimmers, T. Pietsch, A.T. Yachnis, D.W. Pincus, D.A. Steindler, O. Brustle, M. Simon, M. Glas, and B. Scheffler. 2013. Anticancer effects of niclosamide in human glioblastoma. Clinical Cancer Research 19: 4124–4136.

    Article  CAS  PubMed  Google Scholar 

  • Xu, J., Y. Dang, Y.R. Ren, and J.O. Liu. 2010. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proceedings of the National Academy of Sciences USA 107: 4764–4769.

    Article  CAS  Google Scholar 

  • Yang, C.H., H.L. Wang, Y.S. Lin, K.P. Kumar, H.C. Lin, C.J. Chang, C.C. Lu, T.T. Huang, J. Martel, D.M. Ojcius, Y.S. Chang, J.D. Young, and H.C. Lai. 2014. Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma. PLoS ONE 9: e99412.

  • Yang, Z.F., D.W. Ho, M.N. Ng, C.K. Lau, W.C. Yu, P. Ngai, P.W. Chu, C.T. Lam, R.T. Poon, and S.T. Fan. 2008. Significance of CD90(+) cancer stem cells in human liver cancer. Cancer Cell 13: 153–166.

  • Yin, B., Y. Zeng, G. Liu, X.T. Wang, P. Wang, and Y.S. Song. 2014. MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells. International Journal of Clinical and Experimental Pathology 7: 2934–2941.

  • Yo, Y.T., Y.W. Lin, Y.C. Wang, C. Balch, R.L. Huang, M.W. Chan, H.K. Sytwu, C.K. Chen, C.C. Chang, and K.P. Nephew. 2012. Growth inhibition of ovarian tumor–initiating cells by niclosamide. Molecular Cancer Therapeutics 11: 1703–1712.

    Article  CAS  PubMed  Google Scholar 

  • You, S., R. Li, D. Park, M. Xie, G.L. Sica, Y. Cao, Z.Q. Xiao, and X. Deng. 2014. Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer. Molecular Cancer Therapeutics 13: 606–616.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 108: 1167–1174.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Science and Technology Development Fund (FDCT) of Macau SAR (FDCT/119/2013/A3), Matching Research Grant (MRG002/JSS/2015/FHS) and Multi-Year Research Grant (MYRG2015-00181-FHS) of the University of Macau.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joong Sup Shim.

Ethics declarations

Conflict of interest

The authors have declared that there are no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lv, J., Shim, J.S. Existing drugs and their application in drug discovery targeting cancer stem cells. Arch. Pharm. Res. 38, 1617–1626 (2015). https://doi.org/10.1007/s12272-015-0628-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-015-0628-1

Keywords

Navigation